Search Results - "SHOEMAKER, Alex R"
-
1
Activity of the Bcl-2 Family Inhibitor ABT-263 in a Panel of Small Cell Lung Cancer Xenograft Models
Published in Clinical cancer research (01-06-2008)“…Purpose: The purpose of this study was to characterize the activity of the Bcl-2 protein family inhibitor ABT-263 in a panel of small cell lung cancer (SCLC)…”
Get full text
Journal Article -
2
ABT-263 and rapamycin act cooperatively to kill lymphoma cells in vitro and in vivo
Published in Molecular cancer therapeutics (01-10-2008)“…ABT-263 is a potent, orally bioavailable inhibitor of the antiapoptotic Bcl-2 family members Bcl-2, Bcl-x L , and Bcl-w, which is currently in phase I clinical…”
Get full text
Journal Article -
3
Hypoxia-Inducible Factor-1 Inhibition in Combination with Temozolomide Treatment Exhibits Robust Antitumor Efficacy In vivo
Published in Clinical cancer research (01-08-2006)“…Purpose: Inhibiting hypoxia-inducible factor-1 (HIF-1) represents a unique mechanism for cancer therapy. It is conceived that HIF-1 inhibitors may synergize…”
Get full text
Journal Article -
4
The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity
Published in Nature chemical biology (01-03-2017)“…Editorial Summary SUV4-20 members mediate the di- and trimethylation of lysine 20 on histone H4. A chemical screen led to the identification of A-196 as a…”
Get full text
Journal Article -
5
Tumor Regionality in the Mouse Intestine Reflects the Mechanism of Loss of Apc Function
Published in Proceedings of the National Academy of Sciences - PNAS (29-06-2004)“…Inherited colorectal cancer syndromes in humans exhibit regional specificity for tumor formation. By using mice with germline mutations in the adenomatous…”
Get full text
Journal Article -
6
The HPK1 Inhibitor A‑745 Verifies the Potential of Modulating T Cell Kinase Signaling for Immunotherapy
Published in ACS chemical biology (18-03-2022)“…Hematopoietic progenitor kinase 1 (HPK1) is an MAP4K family member within the Ste20-like serine/threonine branch of the kinome. HPK1 expression is limited to…”
Get full text
Journal Article -
7
A small-molecule inhibitor of Bcl-XL potentiates the activity of cytotoxic drugs in vitro and in vivo
Published in Cancer research (Chicago, Ill.) (01-09-2006)“…Inhibition of the prosurvival members of the Bcl-2 family of proteins represents an attractive strategy for the treatment of cancer. We have previously…”
Get full text
Journal Article -
8
PARP inhibitors attenuate chemotherapy-induced painful neuropathy
Published in Journal of the peripheral nervous system (01-09-2012)“…Chemotherapy‐induced peripheral neuropathy (CIPN) is a major toxicity of chemotherapy treatment for which no therapy is approved. Poly(ADP‐ribose) polymerase…”
Get full text
Journal Article -
9
Studies of neoplasia in the Min mouse
Published in Biochimica et biophysica acta (18-04-1997)Get full text
Journal Article -
10
A Resistant Genetic Background Leading to Incomplete Penetrance of Intestinal Neoplasia and Reduced Loss of Heterozygosity in ApcMin/+ Mice
Published in Proceedings of the National Academy of Sciences - PNAS (01-09-1998)“…Previous studies of Min/+ (multiple intestinal neoplasia) mice on a sensitive genetic background, C57BL/6 (B6), showed that adenomas have lost heterozygosity…”
Get full text
Journal Article -
11
N-ethyl-N-nitrosourea treatment of multiple intestinal neoplasia (Min) mice : age-related effects on the formation of intestinal adenomas : cystic crypts, and epidermoid cysts
Published in Cancer research (Chicago, Ill.) (01-10-1995)“…The timing of intestinal tumor initiation in B6-Min/+ mice has been examined by treating mice at 5-35 days of age with a single i.p. injection of the…”
Get full text
Journal Article -
12
Somatic mutational mechanisms involved in intestinal tumor formation in Min mice
Published in Cancer research (Chicago, Ill.) (15-05-1997)“…We have demonstrated previously that intestinal tumor formation in B6 Min/+ mice is always accompanied by loss of the wild-type adenomatous polyoposis coli…”
Get full text
Journal Article -
13
Manipulation of the mouse germline in the study ofMin-induced neoplasia
Published in Seminars in cancer biology (01-10-1996)“…The Min mouse, generated by random germline mutagenesis, carries a mutation in the mouse homolog of APC and is a model of inherited human intestinal…”
Get full text
Journal Article -
14
Homozygosity for the Minallele of Apc results in disruption of mouse development prior to gastrulation
Published in Developmental dynamics (01-08-1995)“…Mutation of the APC (adenomatous polyposis coli) gene is an early event in colon tumor development in humans. Mice carrying Min (multiple intestinal…”
Get full text
Journal Article -
15
The Bcl-2 Family Inhibitor ABT-263 Shows Significant Anti-Tumor Efficacy in Models of B Cell Non-Hodgkin's Lymphoma
Published in Blood (16-11-2006)“…ABT-263 is an orally bioavailable small molecule inhibitor of Bcl-2 family proteins with a Ki of ≤ 1 nM against Bcl-2, Bcl-XL, and Bcl-w. Non-Hodgkin's B-cell…”
Get full text
Journal Article -
16
The Bcl-2 Family Inhibitor ABT-263 Shows Significant but Reversible Thrombocytopenia in Mice
Published in Blood (16-11-2006)“…ABT-263 is an orally bioavailable small molecule inhibitor of Bcl-2 family proteins with a Ki of ≤ 1 nM against Bcl-2, Bcl-XL, and Bcl-w. Potent cytotoxic…”
Get full text
Journal Article -
17
Mlh1 deficiency enhances several phenotypes of Apc(Min)/+ mice
Published in Oncogene (25-05-2000)“…Defects in APC and DNA mismatch repair genes are associated with a strong predisposition to colon cancer in humans, and numerous mouse strains with mutations…”
Get full text
Journal Article -
18
Homozygosity for the Min allele of Apc results in disruption of mouse development prior to gastrulation
Published in Developmental dynamics (01-08-1995)“…Mutation of the APC (adenomatous polyposis coli) gene is an early event in colon tumor development in humans. Mice carrying Min (multiple intestinal…”
Get full text
Journal Article -
19
Manipulation of the mouse germline in the study of Min-induced neoplasia
Published in Seminars in cancer biology (01-10-1996)“…The Min mouse, generated by random germline mutagenesis, carries a mutation in the mouse homolog of APC and is a model of inherited human intestinal…”
Get full text
Journal Article -
20
A resistant genetic background leading to incomplete penetrance of intestinal neoplasia and reduced loss of heterozygosity in Apc Min /+ mice
Published in Proceedings of the National Academy of Sciences - PNAS (01-09-1998)“…Previous studies of Min /+ (multiple intestinal neoplasia) mice on a sensitive genetic background, C57BL/6 (B6), showed that adenomas have lost heterozygosity…”
Get full text
Journal Article